Delayed versus Same-Day Second-Stage Cervical Spine Surgery Authors: James F. Bathon, Omar Zakieh, Claudia Davidson, Alicia M. Hymel, Jacquelyn S. Pennings, Mason W. Young, Mitchell Bowers, Julian G. Lugo-Pico, Raymond J. Gardocki, Scott L. Zuckerman, Byron F. Stephens, Amir M. Abtahi Published: 2026 ABSTRACT Background Two-stage, anterior and posterior, cervical spine surgery is often utilized for complex spinal pathologies. The second stage may be performed on the same day or delayed to a separate day. A variety of considerations influence this decision, yet comprehensive and broad analyses examining predictors and outcomes of same-day versus delayed staging remain limited. Methods A retrospective cohort study was conducted to investigate the effects of same-day versus delayed staging on complications and surgical outcomes. Adults undergoing two-stage cervical procedures were identified using the Quality Outcomes Database. The primary exposure was delaying the second-stage surgery to a separate day, termed the delayed second stage. Demographic, clinical, and preoperative data were analyzed. Outcomes included patient-reported outcome measures (PROMs) and reoperation rates at 3, 12, and 24 months, as well as the 30-day complication rate. Results Among 394 patients (mean age 60.8±10.7, 52.0% male), 27.9% had delayed second-stage surgery, the majority had an anterior approach as the first stage (87.8%), and patients who had delayed second-stage surgery were less likely to have American Society of Anesthesiologists scores ≥3 (43.6% vs. 64.5%, p<0.001). Patients with delayed second-stage surgery had longer operative times (326±37.0 vs. 293±34.0 minutes, p=0.022) and longer hospital stays (4.4±0.79 vs. 3.1±0.54 days, p<0.001), with no significant differences in blood loss, reoperation rates, PROMs at 3, 12, and 24 months, or 30-day complication rates (all p>0.05). Conclusions These results suggest that delaying the second stage may be more a question of resource utilization rather than concern for a negative impact on patient outcomes. Surgeons should acknowledge that either staging strategy, same-day or delayed, results in equivalent clinical outcomes with some differences in perioperative outcomes. The choice to delay second-stage surgery should be patient-centered and consider institutional factors. Introduction Two-stage cervical spine surgery is often utilized to manage complex spinal pathologies that require more than one surgical approach, specifically anterior and posterior approaches. These included, but are not limited to, complex cervical deformities such as severe kyphosis, multilevel cervical myelopathies with instability, combined anterior and posterior pathology, revision surgeries or failed prior fusions, patients with osteoporosis or frailty, spinal infections, tumor resections, and cases with elevated vascular or airway risk1-13). The two operations of staged surgery can be performed on the same day, or the second-stage surgery can be delayed to a separate day, termed here for simplicity as a delayed second stage or delayed stage. The timing of the second surgical stage may be delayed to a separate day, either planned or unplanned, due to a combination of factors. These factors include the patient's overall health, the need for multiple approaches, and the necessity to reduce inflammation1-13). For example, when both anterior and posterior approaches are required, separating the procedures can facilitate patient recovery and simplify surgery. Similarly, patients who are frail may not tolerate prolonged anesthesia, necessitating staged surgeries. There is a proposed concern regarding increased complications associated with delaying the second-stage surgery. Although studies in thoracolumbar deformity surgery suggest increased complications with prolonged intervals between staged procedures, comparable data on delayed second-stage cervical spine surgeries are lacking14,15). This highlights the need for investigation into the predictors and implications of delayed second-stage cervical operations. Further, though several studies explore combined and same-day versus delayed staged cervical procedures, the results are mixed and most focused on specific procedures6-12). Comprehensive and general analyses focusing on the predictors and implications of delaying the second stage of cervical spine surgeries are needed. In a cohort of patients undergoing two-stage cervical spine surgery, this study assessed the effects of same-day versus delayed staging on surgical outcomes and complications. Materials and Methods Study design A national, multicenter cohort study using retrospective data from the Quality Outcome Database (QOD) was conducted for adult patients who underwent two-stage cervical spine procedures using anterior and posterior approaches. This study was completed in full compliance with institutional review board requirements. Patient population The primary exposure was delaying the second-stage surgery to a separate day from the first stage. Included were adult patients undergoing anterior and posterior approach two-stage cervical spine surgery for pathologies including disc herniation, foraminal stenosis, central stenosis, cervical instability, pseudoarthrosis, and adjacent segment disease. Exclusion criteria included patients undergoing concurrent non-cervical procedures. Additionally, QOD exclusion criteria vary by data module but generally exclude patients under 18 years, those undergoing surgery for non-degenerative spine conditions or emergent procedures, individuals with preexisting coagulopathy, and incarcerated individuals. Independent variables Patient demographic and preoperative variables were compared at the time of surgery, including age, sex, body mass index (BMI), insurance status, race, education level, employment status, smoking status, medical comorbidities, symptoms, medications, health status, and primary diagnosis. Baseline preoperative patient-reported outcome measures (PROMs) were also compared and included Numerical Rating Scales scores for neck and arm pain, Neck Disability Index, the modified Japanese Orthopaedic Association (mJOA) score, and quality of life assessed using the EuroQol 5 Dimensions. Perioperative variables, such as estimated blood loss and length of surgery, were compared between the cohorts. Outcomes Primary outcomes included PROMs and reoperation rates at 3, 12, and 24 months. A secondary outcome was the 30-day complication rate. Complications included deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction (MI), urinary tract infection, surgicalite infection (SSI), surgical site hematoma, dysphagia requiring or not requiring NPO or NG tube placement, vocal cord paralysis, cerebrospinal fluid leak, wound dehiscence, new neurological deficit, stroke (cerebrovascular accident [CVA]) identified on magnetic resonance imaging, or pneumonia. Statistical analysis Between those who had same-day staged surgery versus delayed staged surgery, demographic characteristics, clinical characteristics, and baseline PROMs were compared using an unpaired t-test for continuous variables and the Pearson chi-square for categorical variables. A logistic regression was conducted to assess factors predictive of delaying the second stage of surgery. For each PROM, one linear mixed model was run that included repeated measures for time (preoperative to 24 months) within patients. For each mixed-model regression, analyses of variance were conducted to assess whether there were differences in the change in PROMs between groups over time. Models controlled for demographic and clinical covariates, including age, sex, BMI, insurance status, race, education, employment status, smoking status, diabetes, preoperative opioid use, motor deficits, ambulation status, symptom duration, anti-coagulation use, revision status, underlying pathology, American Society of Anesthesiologists (ASA) score, predominant symptom, and pain location. For estimated blood loss (EBL) and length of surgery, multivariable linear regressions were performed. Outliers for EBL were removed, and the models controlled for the same demographic and clinical covariates as described previously. Multivariable Poisson regression was conducted for hospital length of stay (LOS), with outliers removed and controlling for demographic and clinical covariates as described previously. Chi-square tests were performed to assess differences in reoperation rates and 30-day complication rates between groups. All statistical analyses were performed in R version 4.2. Results Patient demographics and clinical characteristics Among 394 patients undergoing two-stage cervical spine procedures, the mean age was 60.8±10.7 years, 205 (52.0%) were male, and 346 (87.8%) had an anterior approach as the first stage of surgery (Table 1, 22). Of these, 110 (27.9%) had their second-stage procedure delayed to a separate day (delayed stage), and 284 (72.1%) had a same-day staged procedure. Patients with delayed staged surgery had a smaller proportion of ASA scores ≥3 (43.6% vs. 64.5%, p<0.001, χ2=14.2, effect size [ES]=0.191) than patients with same-day staged surgery. There was also a significant difference in level of education (p=0.029, χ2=7.1, ES=0.134) and employment status (p=0.008, χ2=7.0, ES=0.133), with higher education and being employed favoring the delayed staged group. Otherwise, there were no differences in other demographic or clinical variables (p>0.05). In a logistic regression predicting delayed second-stage surgery, using patients with sufficient data (n=343), an ASA score ≥3 was the only factor significantly associated with the odds of delaying second-stage surgery (p=0.002, odds ratio=0.43, χ2=9.90, 95% confidence interval [CI]=0.26-0.73) (Table 3). Table 1.Patient Baseline Demographics and Clinical Characteristics (n=394)Overall (n=394)StagingStatisticp-valueEffect sizeDelayed (n=110)Same-day (n=284)n%n%n%Age (yrs), mean (SD)60.810.759.410.761.410.6t=-1.60.106Genderχ2=0.10.782Male20552.0%5650.9%14952.5%Female18948.0%5449.1%13547.5%Insuranceχ2=3.00.224Public19349.1%5045.5%14350.5%Private17143.5%4843.6%12343.5%Liability/disability/Worker’s Comp.297.4%1210.9%176.0%Raceχ2=6.40.096White35289.3%10393.6%24987.7%Black225.6%10.9%217.4%Other174.3%54.5%124.2%Unknown30.8%10.9%20.7%Raceχ2=3.40.067White35290.0%10394.5%24988.3%Non-white3910.0%65.5%3311.7%Education*χ2=7.1 0.029 0.134High school or less19148.5%46a41.8%145a51.1%Greater than high school18045.7%61a55.5%119b41.9%Unknown235.8%3a2.7%20a7.0%Currently employedχ2=7.0 0.008 0.133No24361.8%5651.4%18765.8%Yes15038.2%5348.6%9734.2%BMI, mean (SD)29.16.128.95.229.16.4t=-0.30.739Current smokerχ2=0.30.603No/undocumented30176.4%8678.2%21575.7%Yes9323.6%2421.8%6924.3%Diabetesχ2=0.00.901No31078.7%8779.1%22378.5%Yes8421.3%2320.9%6121.5%Osteoarthritisχ2=0.10.768No26871.3%7672.4%19270.8%Yes10828.7%2927.6%7929.2%Osteoporosisχ2=0.00.887No35192.1%10191.8%25092.3%Yes307.9%98.2%217.7%Predominant symptomχ2=0.30.851Radiculopathy w/ or w/o neck pain12732.6%3633.3%9132.4%Myelopathy w/ or w/o neck or arm pain25264.8%7064.8%18264.8%Mechanical neck pain (cervical instability)102.6%21.9%82.8%Predominant pain locationχ2=0.10.992Neck16141.0%4440.4%11741.2%Arm6015.3%1614.7%4415.5%Neck=arm14436.6%4137.6%10336.3%No pain287.1%87.3%207.0%Preop opioidsχ2=1.60.446No23359.1%6962.7%16457.7%Yes14737.3%3632.7%11139.1%Unknown143.6%54.5%93.2%Motor deficitχ2=3.20.072No19750.0%6357.3%13447.2%Yes19750.0%4742.7%15052.8%Ambulationχ2=1.10.298Not independent7017.8%1614.5%5419.0%Independent32482.2%9485.5%23081.0%Symptom durationχ2=5.40.067<3 months4110.4%1513.6%269.2%≥3 months34387.1%9586.4%24887.3%Unknown102.5%00.0%103.5%Anti-coagulationχ2=0.30.864No28171.3%8072.7%20170.8%Yes9323.6%2421.8%6924.3%Unknown205.1%65.5%144.9%-*Education was significantly different between the two groups. More specifically, the proportion of patients with greater than high school education of the delayed group (55.5%) was significantly greater than the proportion in the same-day group (41.9%). The other groups were of similar proportions. Superscripts indicate which category is significantly different from the other.-Abbreviations: Body Mass Index (BMI)-Missingness: Insurance (1), Employment (1), Osteoarthritis (18), Osteoporosis (13), Predominant symptom (5), location of pain (1), BMI (2). Patient Baseline Demographics and Clinical Characteristics (n=394) -*Education was significantly different between the two groups. More specifically, the proportion of patients with greater than high school education of the delayed group (55.5%) was significantly greater than the proportion in the same-day group (41.9%). The other groups were of similar proportions. Superscripts indicate which category is significantly different from the other. -Abbreviations: Body Mass Index (BMI) -Missingness: Insurance (1), Employment (1), Osteoarthritis (18), Osteoporosis (13), Predominant symptom (5), location of pain (1), BMI (2). Table 2.Patient Baseline PROMs and Surgical Characteristics (n=394)Overall (n=394)StagingStatisticp-valueEffect sizeDelayed (n=110)Same-day (n=284)n%n%n%Revisionχ2=0.00.888No25772.8%7372.3%18473.0%Yes9627.2%2827.7%6827.0%Prior spine surgeryχ2=1.90.174No22457.3%6962.7%15555.2%Yes16742.7%4137.3%12644.8%Underlying pathologyχ2=5.90.431Disc herniation194.8%32.8%165.6%Foraminal stenosis256.4%65.5%196.7%Central stenosis7719.6%2119.3%5619.7%Cervical instability82.0%32.8%51.8%Pseudarthrosis92.3%00.0%93.2%Adjacent segment disease30.8%10.9%20.7%2+ pathologies25264.1%7568.8%17762.3%ASA scoreχ2=14.2 <0.001 0.1911 to 216141.4%6256.4%9935.5%3+22858.6%4843.6%18064.5%First stageχ2=2.30.131Posterior4812.2%98.2%3913.7% No fusion 19 39.6% 1 11.1% 18 46.2% Fusion 29 60.4% 8 88.9% 21 53.8% Anterior34687.8%10191.8%24586.3% No fusion 9 2.6% 1 1.0% 8 3.3% Fusion 337 97.4% 100 99.0% 237 96.7% Second stageχ2=2.00.150Posterior34688.0%10191.8%24586.6% No fusion 30 8.7% 5 5.0% 25 10.2% Fusion 316 91.3% 96 95.0% 220 89.8% Anterior4712.0%98.2%3813.4% No fusion 2 4.3% 0 0.0% 2 5.3% Fusion 45 95.7% 9 100.0% 36 94.7% Baseline neck pain, mean (SD)6.03.06.12.96.03.0t=0.30.783Baseline arm pain, mean (SD)5.23.35.43.25.13.3t=0.90.391Baseline NDI, mean (SD)43.019.942.419.043.320.3t=-0.40.691Baseline EQ-5D, mean (SD)0.50.20.50.20.50.2t=1.60.116Baseline mJOA, mean (SD)11.63.011.83.011.53.0t=0.80.430-Abbreviations: American Society of Anesthesiology score (ASA), Adjacent segment disease (ASD), Neck Dispensability Index (NDI), EuroQol 5 Dimensions (EQ-5D), modified Japanese Orthopedic Association scale (mJOA)-Missingness: Patient Reported Outcome Measures (PROMs), Revision (41), prior spine surgery (3), underlying pathology (1), ASA grade (5), Baseline arm pain (2), mJOA (121). Patient Baseline PROMs and Surgical Characteristics (n=394) -Abbreviations: American Society of Anesthesiology score (ASA), Adjacent segment disease (ASD), Neck Dispensability Index (NDI), EuroQol 5 Dimensions (EQ-5D), modified Japanese Orthopedic Association scale (mJOA) -Missingness: Patient Reported Outcome Measures (PROMs), Revision (41), prior spine surgery (3), underlying pathology (1), ASA grade (5), Baseline arm pain (2), mJOA (121). Table 3.Logistic Regression Predicting Delayed Second Stage Surgery (n=343)Odds ratioWald χ2Lower*Upper*p-valueASA grade0.43 9.90 0.260.73 0.002 Race Non-white0.422.710.151.180.100Baseline arm pain1.061.820.971.160.177Baseline NDI0.991.000.981.010.318Current smoker0.740.940.401.370.334Baseline neck pain0.960.560.861.070.454Age0.990.500.971.020.481BMI0.990.220.951.030.636Diabetic1.150.200.622.140.652Revision1.100.100.631.920.747Female Gender1.070.060.641.770.800χ2(11)=22.0, p=0.024, Nagelkerke R2=0.089*95% CIAbbreviations: Neck Disability Index (NDI), Body Mass Index (BMI) Logistic Regression Predicting Delayed Second Stage Surgery (n=343) χ2(11)=22.0, p=0.024, Nagelkerke R2=0.089 *95% CI Abbreviations: Neck Disability Index (NDI), Body Mass Index (BMI) Patient-reported outcome measures Among patients with sufficient PROM data (n=340), no PROM demonstrated a significant interaction between time and same-day versus delayed staged surgery at 3, 12, and 24 months (p>0.05) (Figure 1 and Table 4). Estimated marginal means of PROMs over time. Estimated marginal means adjusted for age, gender, BMI, insurance, race, education, employment, current smoking status, diabetes, preoperative opioids, motor deficit, ambulation, symptom duration, anti-coagulation, revision status, underlying pathology, ASA grade, predominant symptom, and pain location. ASA: American Society of Anesthesiologists; EQ-5D: EuroQol 5 Dimensions; mJOA: modified Japanese Orthopedic Association scale; NDI: Neck Dispensability Disability Index; PROM: Patient Reported Outcome Measures Table 4.Linear Mixed Model of Time Interaction for PROMs by ProcedureInteraction of time by procedure typeMeasureNFpNeck pain340F (3, 561)=0.10.958Arm pain339F (3, 547)=0.70.542NDI340F (3, 521)=0.30.845EQ-5D340F (3, 527)=1.30.285mJOA242F (3, 367)=0.20.863Abbreviations: Neck Dispensability Index (NDI), EuroQol 5 Dimensions (EQ-5D), modified Japanese Orthopedic Association scale (mJOA) Linear Mixed Model of Time Interaction for PROMs by Procedure Abbreviations: Neck Dispensability Index (NDI), EuroQol 5 Dimensions (EQ-5D), modified Japanese Orthopedic Association scale (mJOA) Perioperative variables and complications Although greater EBL and longer length of surgery were observed with delayed second-stage surgery in the linear regression of 324 patients assessed, when controlling for covariates, only length of surgery was significant (326±37.0 vs. 293±34.0 minutes, p=0.022, β=-33.4, 95% CI=-62.0 to -4.8), and EBL was not significant (192±70.5 vs. 172±64.8 mL, p=0.478) (Figure 2). Among the 316 patients with complete data, those with delayed second-stage surgery had longer hospital stays (4.4±0.79 vs. 3.1±0.54 days, p<0.001, incidence rate ratio=0.71, 95% CI=0.62-0.81) than patients with same-day staged surgery (Figure 3). There was no significant differences in reoperation rates at 3, 12, and 24 months (all p>0.05) or in 30-day complication rates, either individual (such as SSI or dysphagia) or aggregate complications (18.8% vs. 15.7%, p=0.476), between patients with delayed and same-day second-stage surgery (Table 5, Table 6, and Supplemental Table 1). Linear regression assessing intraoperative outcomes. Estimated marginal means adjusted for age, sex, BMI, insurance, race, education, employment, current smoking status, diabetes, preoperative opioids, motor deficit, ambulation, symptom duration, anti-coagulation, revision status, underlying pathology, ASA grade, predominant symptom, and pain location. ASA: American Society of Anesthesiologists; BMI: body mass index; EMM: estimated marginal means Poisson regression assessing length of stay. Incidence rates adjusted for age, sex, BMI, insurance, race, education, employment, current smoking status, diabetes, preoperative opioids, motor deficit, ambulation, symptom duration, anti-coagulation, revision status, underlying pathology, ASA grade, predominant symptom, and pain location. Poisson regression same-day/delayed 2nd stage surgery: Incidence rate ratio=0.71, 95% CI=0.62-0.91, p<0.001. ASA: American Society of Anesthesiologists; BMI: body mass index; CI: confidence interval Table 5.Comparison of ReoperationsOverallDelayedSame-dayStatisticp-valuen%n%n%Return to ORWithin 3 months1.70.196No28191.2%8188.0%20092.6%Yes278.8%1112.0%167.4%Within 12 months3.20.075No18693.5%5688.9%13095.6%Yes136.5%711.1%64.4%Within 24 months01.000No4595.7%2295.7%2395.8%Yes24.3%14.3%14.2% Comparison of Reoperations Table 6.30-Day Complication RatesOverallDelayedSame-dayStatisticp-valuen%n%n%Any complication0.50.476No29283.4%8281.2%21084.3%Yes5816.6%1918.8%3915.7%Complications included deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction (MI), urinary tract infection (UTI), surgical site infection (SSI), surgical site hematoma, dysphagia requiring and not requiring NPO or NG tube, vocal cord paralysis, cerebrospinal fluid leak, wound dehiscence, new neurological deficit, stroke (CVA) on MRI, or pneumonia. 30-Day Complication Rates Complications included deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction (MI), urinary tract infection (UTI), surgical site infection (SSI), surgical site hematoma, dysphagia requiring and not requiring NPO or NG tube, vocal cord paralysis, cerebrospinal fluid leak, wound dehiscence, new neurological deficit, stroke (CVA) on MRI, or pneumonia. Discussion This study sought to investigate the effects of same-day versus delayed stage anterior and posterior cervical spine surgery on complications and patient outcomes. Among a cohort of patients undergoing staged cervical spine procedures, the analysis found that patients who had delayed second-stage surgery, defined as surgeries with the second stage performed on a separate day from the first-stage procedure, were less likely to have an ASA score ≥3. Greater medical comorbidity (ASA score ≥3) was more common in patients who underwent both stages of surgery on the same day. This finding is somewhat counterintuitive, as one might expect patients with higher comorbidity and complexity to be more likely to require a break between surgical stages due to anesthetic or physiological risk. This finding may be due to a preference for minimizing repeated anesthetic exposure or the desire to reduce cumulative perioperative stress in patients with greater medical complexity. Alternatively, the fact that more same-day staged procedures occurred in patients with an ASA score ≥3 may imply that more same-day staged surgeries were smaller surgeries, whereas more of the delayed-stage surgeries were larger surgeries involving more levels in patients with fewer medical comorbidities (ASA score of 1 or 2). It is possible that there were patients with an ASA score ≥3 who may have benefited from a larger delayed staged surgery but were treated non-operatively, given medical comorbidities, possibly explaining the counterintuitive finding that patients with an ASA score ≥3 had fewer delayed-stage procedures. Furthermore, the higher proportion of patients with an ASA score ≥3 undergoing same-day staging could reflect selection bias. Surgeons may intentionally avoid prolonged or multi-day staged procedures in patients with greater medical complexity, opting instead for shorter same-day operations to minimize repeated anesthetic exposure and cumulative physiological stress. This pattern suggests that medical comorbidity influenced staging decisions, which may partially explain the counterintuitive association observed. Regardless, this factor was controlled for in our analysis, minimizing the impact of bias. Delayed second-stage surgery was associated with increased LOS by approximately 1 day and an average increase in operative time of approximately 30 minutes. However, there were no differences in EBL, PROMs through 24 months, or 30-day complications, including DVT, PE, MI, infection, dysphagia, CVA, or pneumonia. These results suggest that, though surgical staging across days may add logistical complexity and increase healthcare resource utilization, it does not appear to impact patient-reported recovery, functional improvement, or complication rates, including reoperation rates. This finding is contrary to the assumption that delayed staged procedures increase the risk of medical complications14,15). However, it is important to note that although reoperation rates were not statistically different, delayed staging was associated with an approximately 2.5-fold higher reoperation rate at 12 months (11.1% vs. 4.4%), which should be considered. Overall, previous studies comparing combined anterior-posterior cervical procedures with staged approaches have similarly shown mixed results, often limited by smaller sample sizes or a focus on narrow indications (e.g., deformity or infection)6-12). These findings contribute a broader and more generalizable dataset and demonstrate that perioperative morbidity, including a mildly longer hospitalization and operative duration, may be the most tangible consequence of delayed-stage surgery, with limited associated differences in complications or patient outcomes. The rationale for staging remains multifactorial, including concerns about soft tissue swelling, airway risk, and patient endurance, especially in complex reconstructions requiring both anterior and posterior approaches1-13). Regardless, the lack of outcome differences between groups reinforces that clinical decisions regarding the timing of staged surgeries should be individualized, balancing surgical risk, patient comorbidity, and institutional factors. From a patient perspective, same-day versus delayed-stage surgery is essentially equivalent, given the lack of differences in PROMs or complications. For surgeons and hospitals, the question of staged surgery timing is more nuanced, given the increased resource utilization associated with delayed staging and changing financial reimbursement structures. It is important to recognize several limitations. The observational and retrospective design introduces potential for unmeasured confounding or missed data. Further, patient-specific reasons for delaying the second stage, whether planned or emergent, could not be ascertained from the database, limiting specificity, and represent an interesting area for future study. Although the generalizability of the study is a strength, it would be interesting to assess the benefits or outcomes within specific pathology subgroups or case types. Also, this study did not explore the number of levels fused, radiographic data, or other specific complications, such as intensive care unit admission or duration of mechanical ventilation. Further, reintubation can be a concern in anterior-posterior surgeries, especially same-day cases, but this discrete variable was not available in the QOD. Understanding these aforementioned factors could provide additional insight into the topic. Finally, although robust, the QOD dataset may not fully reflect all surgical techniques or institutional practices, especially in lower-volume or lower-resourced centers. Conclusions In this cohort study of patients undergoing two-stage cervical spine surgery, it was less common for patients who had delayed second-stage surgery to have a high ASA score (≥3). Delaying the second stage to a separate day was associated with longer operative times and hospital stays but did not show differences in complications, reoperation rates, or patient-reported outcomes through 24 months. These findings suggest that delayed staging may be more strongly related to resource utilization rather than concerns about negative impacts on patient outcomes. Surgeons should acknowledge that both staging strategies, same-day and delayed, result in similar clinical outcomes, with some differences in perioperative outcomes. Therefore, the decision to delay second-stage surgery should be patient-centered and consider institutional factors. Author contributions: Formal analysis, data curation: J.F.B., C.D., A.M.H., J.S.P. Project administration: J.F.B. Writing: original draft preparation, writing: review & editing: J.F.B., O.Z., C.D., A.M.H., J.S.P., M.W.Y., M.B., J.G.L., R.J.G., S.L.Z., B.F.S., A.M.A. Conceptualization, methodology: O.Z., M.W.Y., M.B., J.G.L., R.J.G., S.L.Z., B.F.S., A.M.A. Supervision: J.S.P., J.G.L., R.J.G., S.L.Z., B.F.S., A.M.A. Conflicts of Interest and Source of Funding Dr. Abtahi received institutional research support from Stryker Spine. Dr. Gardocki is a consultant and teaching surgeon for Joimax, a consultant for Arthrex, a teaching surgeon and consultant with royalties for Integrity Implants, and a consultant with royalties for Spineology. Dr. Pennings is a consultant for 3Spine and Steamboat Orthopedic and Spine Institute. Dr. Stephens is a consultant for Nuvasive and receives institutional research support from Nuvasive and Stryker Spine. Dr. Zuckerman reports being an unaffiliated neurotrauma consultant for the National Football League. No other perceived conflict of interest by any of the listed authors. Ethics, Consent, and IRB Approval: This study was in full compliance with the Vanderbilt IRB, and appropriate guidelines were followed. No consent was required for this study per the IRB, given the retrospective nature of the study and use of a national database. Supplementary Material